Inovio Pharmaceuticals
INO
#8897
Rank
HK$1.10 B
Marketcap
HK$16.11
Share price
2.48%
Change (1 day)
-48.49%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$0.60 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's total liabilities are HK$0.60 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Inovio Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$0.34 B-17.12%
2023-12-31HK$0.41 B-57.53%
2022-12-31HK$0.98 B31.32%
2021-12-31HK$0.75 B23.15%
2020-12-31HK$0.60 B-43.51%
2019-12-31HK$1.07 B212.58%
2018-12-31HK$0.34 B-1.27%
2017-12-31HK$0.34 B-10.41%
2016-12-31HK$0.39 B32.83%
2015-12-31HK$0.29 B87.08%
2014-12-31HK$0.15 B-42.76%
2013-12-31HK$0.27 B244.3%
2012-12-31HK$79.69 M-22.53%
2011-12-31HK$0.10 B47.43%
2010-12-31HK$69.77 M-53.72%
2009-12-31HK$0.15 B-1.87%
2008-12-31HK$0.15 B125.44%
2007-12-31HK$68.14 M-29.61%
2006-12-31HK$96.81 M126.69%
2005-12-31HK$42.7 M1.73%
2004-12-31HK$41.97 M358.45%
2003-12-31HK$9.15 M-30.68%
2002-12-31HK$13.2 M1.4%
2001-12-31HK$13.02 M
2001-03-31HK$12.44 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
HK$900.17 B 149,869.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$883.85 B 147,151.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$6.70 B 1,016.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$486.82 B 81,005.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$604.38 B 100,591.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$477.07 B 79,381.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
HK$288.62 B 47,986.00%๐Ÿ‡บ๐Ÿ‡ธ USA